JP2005524730A5 - - Google Patents

Download PDF

Info

Publication number
JP2005524730A5
JP2005524730A5 JP2004501483A JP2004501483A JP2005524730A5 JP 2005524730 A5 JP2005524730 A5 JP 2005524730A5 JP 2004501483 A JP2004501483 A JP 2004501483A JP 2004501483 A JP2004501483 A JP 2004501483A JP 2005524730 A5 JP2005524730 A5 JP 2005524730A5
Authority
JP
Japan
Prior art keywords
diblock copolymer
valerolactone
polymer
dosage form
polymer block
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004501483A
Other languages
English (en)
Japanese (ja)
Other versions
JP4300184B2 (ja
JP2005524730A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/004368 external-priority patent/WO2003093344A1/en
Publication of JP2005524730A publication Critical patent/JP2005524730A/ja
Publication of JP2005524730A5 publication Critical patent/JP2005524730A5/ja
Application granted granted Critical
Publication of JP4300184B2 publication Critical patent/JP4300184B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004501483A 2002-05-03 2003-04-24 ポリマー性マイクロエマルション Expired - Fee Related JP4300184B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37790102P 2002-05-03 2002-05-03
PCT/EP2003/004368 WO2003093344A1 (en) 2002-05-03 2003-04-24 Polymeric microemulsions

Publications (3)

Publication Number Publication Date
JP2005524730A JP2005524730A (ja) 2005-08-18
JP2005524730A5 true JP2005524730A5 (https=) 2006-06-08
JP4300184B2 JP4300184B2 (ja) 2009-07-22

Family

ID=29401581

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004501483A Expired - Fee Related JP4300184B2 (ja) 2002-05-03 2003-04-24 ポリマー性マイクロエマルション

Country Status (22)

Country Link
US (3) US20060034797A1 (https=)
EP (1) EP1504047B1 (https=)
JP (1) JP4300184B2 (https=)
KR (1) KR20040111466A (https=)
CN (1) CN1290893C (https=)
AR (1) AR039522A1 (https=)
AT (1) ATE380834T1 (https=)
AU (1) AU2003222310B2 (https=)
BR (1) BR0309688A (https=)
CA (1) CA2483282C (https=)
DE (1) DE60318035T2 (https=)
EA (1) EA008244B1 (https=)
ES (1) ES2298510T3 (https=)
IL (1) IL164977A (https=)
MX (1) MXPA04010778A (https=)
MY (1) MY139066A (https=)
NO (1) NO20045283L (https=)
NZ (1) NZ536294A (https=)
PL (1) PL220850B1 (https=)
TW (1) TWI310388B (https=)
WO (1) WO2003093344A1 (https=)
ZA (1) ZA200408854B (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638522B2 (en) * 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US8101629B2 (en) * 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
DK1529032T3 (da) * 2002-08-09 2013-07-08 Janssen Pharmaceutica Nv Fremgangsmåder til fremstilling af 4-4-4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)aminobenzonitrill
WO2004035013A2 (en) * 2002-10-21 2004-04-29 L'oreal Process for dissolving lipophilic compounds, and cosmetic composition
US7968115B2 (en) * 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
US8784881B2 (en) 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
JP4929567B2 (ja) * 2004-08-05 2012-05-09 コニカミノルタエムジー株式会社 ポリマーミセル含有製剤の製造方法
DK1797038T3 (da) * 2004-09-29 2012-09-03 Bayer Pharma AG Termodynamisk stabil form af bay 43-9006-tosylat
WO2006042215A1 (en) * 2004-10-08 2006-04-20 Janssen Pharmaceutica, N.V. 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
US7202209B2 (en) * 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7884119B2 (en) 2005-09-07 2011-02-08 Rigel Pharmaceuticals, Inc. Triazole derivatives useful as Axl inhibitors
JP4892264B2 (ja) * 2006-03-30 2012-03-07 高田製薬株式会社 リスペリドン水性液剤
WO2007136134A1 (ja) * 2006-05-23 2007-11-29 Nanocarrier Co., Ltd. 疎水性薬物内包ポリマーミセルの製造方法
KR100795214B1 (ko) * 2006-08-22 2008-01-21 이화여자대학교 산학협력단 온도 민감성 졸-젤 전이 폴리(에틸렌글리콜)/폴리(카보네이트) 블록 공중합체 및 이의 제조방법
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
US20100063112A1 (en) * 2006-11-09 2010-03-11 Bayer Schering Pharma Aktiengesellschaft Polymorph iii of 4-[4-(amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
EP2089363A1 (en) * 2006-11-14 2009-08-19 Bayer Schering Pharma Aktiengesellschaft Polymorph ii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]n-methylpyridine-2-carboxamide
US8012965B2 (en) 2006-12-29 2011-09-06 Rigel Pharmaceuticals, Inc. Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
CA2710046C (en) 2006-12-29 2016-02-09 Rigel Pharmaceuticals, Inc. N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
WO2008083353A1 (en) 2006-12-29 2008-07-10 Rigel Pharmaceuticals, Inc. Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
JP2010514810A (ja) 2006-12-29 2010-05-06 ライジェル ファーマシューティカルズ， インコーポレイテッド Ａｘｌインヒビターとして有用な置換トリアゾール
EP2078010B1 (en) 2006-12-29 2014-01-29 Rigel Pharmaceuticals, Inc. Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
CA2688036C (en) * 2007-05-25 2016-08-16 The University Of British Columbia Formulations for the oral administration of therapeutic agents and related methods
FR2919296A1 (fr) * 2007-07-25 2009-01-30 Rhodia Operations Sas Ouverture de cycles epoxy par des carbenes.
EP2205592B1 (en) 2007-10-26 2013-05-08 Rigel Pharmaceuticals, Inc. Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
ES2537480T3 (es) 2008-07-09 2015-06-08 Rigel Pharmaceuticals, Inc. Triazoles sustituidos con heteroarilo policíclicos útiles como inhibidores de Axl
JP5613156B2 (ja) 2008-07-09 2014-10-22 ライジェル ファーマシューティカルズ， インコーポレイテッド Ａｘｌ阻害剤として有用な架橋二環ヘテロアリール置換トリアゾール
RU2546529C2 (ru) 2008-12-24 2015-04-10 Тиботек Фармасьютикалз Имплантируемые устройства для лечения вич
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
CN101444510B (zh) * 2008-12-31 2011-03-09 南京卡文迪许生物工程技术有限公司 含有伏立康唑的药物制剂及其制备方法
PL2387395T3 (pl) 2009-01-16 2015-03-31 Rigel Pharmaceuticals Inc Inhibitory Axl do zastosowania w terapii skojarzonej do zapobiegania, leczenia lub postępowania z nowotworem przerzutowym
CN101531756B (zh) * 2009-04-16 2011-06-15 山东大学 一种水溶性聚乙二醇/聚乳酸多嵌段聚碳酸酯的制备方法
US20100273730A1 (en) * 2009-04-27 2010-10-28 Innopharmax, Inc. Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof
MX364947B (es) 2009-10-01 2019-05-15 Adare Pharmaceuticals Inc Composiciones de corticosteroides administradas oralmente.
WO2011050457A1 (en) 2009-10-26 2011-05-05 The University Of British Columbia Stabilized formulation for oral administration of therapeutic agents and related methods
US9023897B2 (en) * 2010-12-29 2015-05-05 Medincell Biodegradable drug delivery compositions
EP2634179A1 (en) * 2012-02-28 2013-09-04 Sanofi Functional PLA-PEG copolymers, the nanoparticles thereof, their preparation and use for targeted drug delivery and imaging
ITTO20130431A1 (it) * 2013-05-28 2014-11-29 Fond Istituto Italiano Di Tecnologia Copolimero e nanoparticelle da esso ottenute per la veicolazione di un farmaco
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CN104523592B (zh) * 2015-01-26 2017-03-15 湖北工业大学 甲泼尼龙醋酸酯注射用自微乳制剂及其制备方法
US20200155449A1 (en) 2015-11-16 2020-05-21 Medincell Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
EP4137323A1 (en) 2021-08-18 2023-02-22 Imertech Hydraulic binder with low carbon footprint and high early strength
CN117064767A (zh) * 2023-09-05 2023-11-17 深圳市护家科技有限公司 一种肤感优异的水包油组合物、外用皮肤制剂及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3779838T2 (de) * 1986-09-05 1992-12-24 American Cyanamid Co Beschichtung fuer chirurgische faeden.
ES2058081T3 (es) * 1986-09-05 1994-11-01 American Cyanamid Co Poliesteres que contienen bloques de oxido de alquileno como sistemas de administracion de medicamentos.
US4716203A (en) * 1986-09-05 1987-12-29 American Cyanamid Company Diblock and triblock copolymers
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
DE4130933A1 (de) * 1991-09-13 1993-03-18 Schering Ag Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln
DE4219536A1 (de) * 1992-06-15 1993-12-16 Herbertz Heinz Verfahren und Zentrifuge zum Entwaessern in Postenwaschanlagen
JP3220331B2 (ja) * 1993-07-20 2001-10-22 エチコン・インコーポレーテツド 非経口投与用の吸収性液体コポリマー類
AU706434B2 (en) * 1994-10-18 1999-06-17 Ethicon Inc. Injectable liquid copolymers for soft tissue repair and augmentation
US6413539B1 (en) * 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US5518774A (en) * 1995-06-26 1996-05-21 Olin Corporation In-can and dry coating antimicrobial
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
DE69734060T2 (de) * 1996-05-24 2006-06-29 Angiotech Pharmaceuticals, Inc., Vancouver Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
AU6169998A (en) * 1997-02-14 1998-09-08 Chandrashekar Pathak Biocompatible polymers and methods for their use
US6211249B1 (en) * 1997-07-11 2001-04-03 Life Medical Sciences, Inc. Polyester polyether block copolymers
IL122933A (en) * 1998-01-14 2005-03-20 Efrat Biopolymers Ltd Polymeric carrier for delivery of a bioactive molecule
SK287270B6 (sk) * 1998-11-10 2010-05-07 Janssen Pharmaceutica N. V. Derivát pyrimidínu
KR100288103B1 (ko) * 1998-12-26 2001-05-02 윤덕용 폴리에테르가 그라프트된 생분해성 지방족 폴리에스테르 및 그의 제조방법
MXPA03004112A (es) * 2000-11-09 2003-08-19 Astrazeneca Ab Composicion farmaceutica oral que contiene un copolimero de bloque.
US6617995B2 (en) * 2001-09-24 2003-09-09 Microline Co., Ltd. Radar detector
ES2261605T3 (es) * 2002-01-10 2006-11-16 Davey Bickford Iniciador electropirotecnico.

Similar Documents

Publication Publication Date Title
JP2005524730A5 (https=)
CA2483282A1 (en) Polymeric microemulsions
US9913910B2 (en) Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron
ES2469641T3 (es) Material polim�rico anfif�lico
CA2407298A1 (en) Mixtures of triblock polyesterpolyethylene glycol copolymers
CN101155844A (zh) 聚乙二醇-聚缩醛和聚乙二醇-聚缩醛-聚原酸酯接枝共聚物和药物组合物
US20080015210A1 (en) Base-Stabilized Polyorthoester Formulations
WO2007133751A2 (en) Base-stabilized polyorthoester formulations
US20060235084A1 (en) PEG-polyacetal diblock and triblock copolymers and pharmaceutical compositions
CA2601547A1 (en) Peg-poly(ortho ester) graft copolymers and pharmaceutical compositions
WO2014185309A1 (ja) 癒着防止材及びその製造方法
EP2096938A2 (en) Degradable chewing gum
HK40054578A (en) Semi-solid delivery vehicle and pharmaceutical compositions
HK40003214B (en) Semi-solid delivery vehicle and pharmaceutical compositions
HK40003214A (en) Semi-solid delivery vehicle and pharmaceutical compositions
TH76143A (th) สารผสมที่มีการปลดปล่อยแบบเนิ่น, กระบวนการสำหรับการผลิตสารชนิดเดียวกัน และการใช้สารชนิดเดียวกัน
HK1117853A (en) Peg-polyacetal and peg-polyacetal-poe graft copolymers and pharmaceutical compositions
TH77100A (th) สารผสมทางเภสัชกรรม
HK1213477B (en) Semi-solid delivery vehicle and pharmaceutical compositions